| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/1994 | EP0602478A1 Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives |
| 06/22/1994 | EP0602458A1 1,4-Benzoxazine derivatives |
| 06/22/1994 | EP0602454A1 N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines |
| 06/22/1994 | EP0602306A1 Retroviral protease inhibitors |
| 06/22/1994 | EP0602209A1 Oxytocin antagonist |
| 06/22/1994 | EP0602172A1 A method for treatment of patients with chronic liver disease |
| 06/22/1994 | EP0602157A1 Ribosomal structure derived from the genomic rna structure of the delta hepatitus virus |
| 06/22/1994 | EP0602149A1 Composition and method for reducing cholesterol concentration |
| 06/22/1994 | EP0602125A1 Quinazoline derivatives and their preparation |
| 06/22/1994 | EP0602123A1 Steroid sulphatase inhibitors |
| 06/22/1994 | EP0602118A1 $i(IN VIVO) GENE TRANSFER USING IMPLANTED RETROVIRAL PRODUCER CELLS |
| 06/22/1994 | EP0602112A1 High content ibuprofen agglomerates and process to prepare them |
| 06/22/1994 | EP0602097A1 New tricyclic thiazol and oxazol derivates with antiviral action. |
| 06/22/1994 | EP0602069A1 Retroviral protease inhibitors |
| 06/22/1994 | EP0602060A1 Spirocyclic benzopyran imidazolines, their preparation and their use as potassium channel activators |
| 06/22/1994 | EP0602028A1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them. |
| 06/22/1994 | EP0602026A1 New organic derivative of a metal with a phospholipid structure, use of this derivative as a biomediator, process for isolating this derivative and pharmaceutical compositions containing it |
| 06/22/1994 | EP0602025A1 N-(1-(2-carboxyethyl)cycloalkyl carbonyl)-beta-alanine derivatives for pharmaceutical use |
| 06/22/1994 | EP0496729B1 Medicament for the treatment of cryptosporidiosis |
| 06/22/1994 | EP0321490B1 Inhibition of interleukin-1 production by monocytes and/or macrophages |
| 06/22/1994 | EP0205586B1 Composition comprising udpg and other anti-tumor drugs for treatment of tumors |
| 06/22/1994 | CN1088223A Crosslinked polymeric ammonium salts |
| 06/22/1994 | CN1088213A Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/22/1994 | CN1088209A Heterocyclic compounds |
| 06/22/1994 | CN1088207A Pyrimidines compounds |
| 06/22/1994 | CN1088205A Improvements in or relating to benzothiophenes |
| 06/22/1994 | CN1088203A Novel treatment |
| 06/22/1994 | CN1088202A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/22/1994 | CN1088201A Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 06/22/1994 | CN1088199A N-substituted anilines |
| 06/22/1994 | CN1088197A Substituted benzoate derivatives |
| 06/22/1994 | CN1088095A Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer |
| 06/22/1994 | CN1088094A Application of 8-chloro-adenosine antineoplastic |
| 06/22/1994 | CN1088093A Novel pharmaceutical compositions |
| 06/22/1994 | CN1088091A Programmed release tablets containing naproxen |
| 06/22/1994 | CA2112027A1 Prostaglandin combinations in glaucoma therapy |
| 06/22/1994 | CA2111902A1 Antitumor compositions and methods of treatment |
| 06/22/1994 | CA2111895A1 Heterocyclic compounds |
| 06/22/1994 | CA2111875A1 P-[bis(2-chloroethyl)amino]phenylalanine derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 06/22/1994 | CA2111778A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
| 06/22/1994 | CA2111635A1 Therapeutic for gram-positive diseases of aquatic species |
| 06/22/1994 | CA2111631A1 Bile acid sequestrant |
| 06/21/1994 | US5322944 Process for the synthesis of enantiomers of 3-aminochroman compounds |
| 06/21/1994 | US5322859 Topically applying to affected eye to lower intraocular pressure |
| 06/21/1994 | US5322858 Antimicrobial, antiparasitic agents |
| 06/21/1994 | US5322857 Food products having increased potassium content and use thereof in enhancing gastric acid response |
| 06/21/1994 | US5322856 Dual quaternary ammonium chloride, para-tert-amyl phenol, ortho-phenyl phenol, citric or acetic acid, sodium citrate, isopropyl or ethyl alcohol, triethanolamine hydrochloride and water |
| 06/21/1994 | US5322854 Antibiotic |
| 06/21/1994 | US5322852 Aminooxy piperidines as ornithine decarboxylase inhibitors |
| 06/21/1994 | US5322850 Antiallergic piperidine derivatives of benzimidazole |
| 06/21/1994 | US5322849 Benzoxazalinonyl and benzothiazolinonyl ethyl isonicotine amides and piperidonamides |
| 06/21/1994 | US5322848 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 06/21/1994 | US5322846 Useful in treatment of cardiovascular diseases associated with hyperactivity of the sympathetic nervous system |
| 06/21/1994 | US5322844 Cardiovascular disorders, antiinflammatory agents, antiallergens |
| 06/21/1994 | US5322843 Treating sleep disorders |
| 06/21/1994 | US5322842 Tricyclic benzodiazepine derivates, their preparation, and pharmaceutical compositions containing them |
| 06/21/1994 | US5322841 Method for producing neutral glucans for pharmaceutical applications |
| 06/21/1994 | US5322840 Treatment of hyperlipemia and hypertriglyceridemia |
| 06/21/1994 | US5322698 Homogenizing with anhydrous alkaline earth metal salt and microcrystalline cellulose, compressing |
| 06/21/1994 | US5322692 Containing LLF28249 or derivative, glycerol monostearate, carnauba wax, barium sulfate |
| 06/21/1994 | US5322689 Copolymer of acrylic acid and fatty alcohol acrylate ester crosslinked with polyalkenyl polyether of polyhydric alcohol, volatile aromatic compound |
| 06/21/1994 | US5322688 Method of preparation of an extract from Ginkgo biloba leaves and pharmaceuticals containing the extract |
| 06/21/1994 | US5322681 Chelating compounds |
| 06/21/1994 | CA2002343C Tailored beta-prime stable triglyceride hardstock |
| 06/21/1994 | CA1330347C Benzamides and their salts |
| 06/21/1994 | CA1330346C Caffeic acid esters and methods of preparing and using same |
| 06/21/1994 | CA1330344C Tetrahydrocarbazole esters |
| 06/21/1994 | CA1330343C Biologically active compounds |
| 06/21/1994 | CA1330341C Imidazole derivatives ii |
| 06/21/1994 | CA1330307C Pharmaceutical compositions containing a 3-hydroxybutanoic acid derivative chosen from oligomers of that acid and esters of that acid or of these oligomers with 1,3-butanediol |
| 06/21/1994 | CA1330306C Medicament for the treatment and prevention of nausea and vomiting |
| 06/21/1994 | CA1330305C Heparin fragments and fractions with anti-hiv action |
| 06/21/1994 | CA1330303C Composition and process to enhance the efficacy of a fish vaccine |
| 06/21/1994 | CA1330299C Composition of anticoagulants |
| 06/21/1994 | CA1330298C Preparations for preventing adhesions of organs and parts of organs |
| 06/21/1994 | CA1330297C Aqueous solution of fat-soluble substance |
| 06/21/1994 | CA1330296C Agents against fish parasites |
| 06/21/1994 | CA1330295C Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| 06/19/1994 | CA2111775A1 Pharmaceutical and/or cosmetic preparation |
| 06/19/1994 | CA2111774A1 Use of alkanolamines |
| 06/19/1994 | CA2111773A1 Phospholipid composition |
| 06/19/1994 | CA2111130A1 Lanolin/lanolin acid ester skin treatment composition |
| 06/19/1994 | CA2111031A1 Crystal forms of optically active isoindolines and their use |
| 06/19/1994 | CA2110529A1 Diazepine derivatives |
| 06/18/1994 | CA2111644A1 Use of thrombin inhibitors for the inhibition of ocular fibrin formation |
| 06/18/1994 | CA2085632A1 Compositions comprising vitamin d precursors, analogs thereof and their use |
| 06/17/1994 | CA2111560A1 Stable pharmaceutical composition of fumagillol derivatives |
| 06/17/1994 | CA2111454A1 Retroviral protease inhibitors |
| 06/17/1994 | CA2111362A1 Imidazopyridines |
| 06/16/1994 | DE4308406C1 Contraceptive compsn. with reduced hormone dose and reduced side-effects - contg. synergistic mixt. of biogenic, synthetic oestrogen and gestagen |
| 06/16/1994 | DE4241632A1 New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis |
| 06/16/1994 | DE4235220A1 Gestagen wirksame 19,11ß-überbrückte 4-Estrene Progestin effective 19,11ß-bridged 4-Estrenes |
| 06/16/1994 | CA2111385A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 06/15/1994 | EP0642516A4 Macrocyclic immunomodulators. |
| 06/15/1994 | EP0601977A1 Aromatic hydroxyamidine derivatives and their use as leukotriene B4 receptor anagonists |
| 06/15/1994 | EP0601930A1 4-methyl-1,3-oxazone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/15/1994 | EP0601914A1 Pharmaceutical compositions containing diltiazem and molsidomine |
| 06/15/1994 | EP0601911A1 Acylamino acids obtained by acylation of protein hydrolipates and antimicrobial, antiparasitic or cosmetic compositions containing them |
| 06/15/1994 | EP0601698A1 Topical composition comprising tocopherol |